NO20055167L - Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents

Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Info

Publication number
NO20055167L
NO20055167L NO20055167A NO20055167A NO20055167L NO 20055167 L NO20055167 L NO 20055167L NO 20055167 A NO20055167 A NO 20055167A NO 20055167 A NO20055167 A NO 20055167A NO 20055167 L NO20055167 L NO 20055167L
Authority
NO
Norway
Prior art keywords
preparation
methods
pharmaceutical compositions
compositions containing
benzothiadiazine compounds
Prior art date
Application number
NO20055167A
Other languages
English (en)
Other versions
NO20055167D0 (no
Inventor
Patrice Desos
Pierre Lestage
Alexis Cordi
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of NO20055167D0 publication Critical patent/NO20055167D0/no
Publication of NO20055167L publication Critical patent/NO20055167L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Forbindelser med formel (l): · hvori: R1 representerer alkyl substituert med ett eller flere halogenatomer, R2 representerer hydrogen, halogen eller OH, R3 representerer en usubstituert eller substituert arylgruppe, deres isomerer, og også addisjonssalter derav. Medikamenter.
NO20055167A 2004-11-03 2005-11-03 Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO20055167L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0411690A FR2877338B1 (fr) 2004-11-03 2004-11-03 Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
NO20055167D0 NO20055167D0 (no) 2005-11-03
NO20055167L true NO20055167L (no) 2006-05-04

Family

ID=34950935

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055167A NO20055167L (no) 2004-11-03 2005-11-03 Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (26)

Country Link
US (2) US7268130B2 (no)
EP (1) EP1655030B1 (no)
JP (1) JP2006151972A (no)
KR (1) KR100818431B1 (no)
CN (1) CN100396673C (no)
AR (1) AR051149A1 (no)
AT (1) ATE381338T1 (no)
AU (1) AU2005229698A1 (no)
BR (1) BRPI0504780A (no)
CA (1) CA2524859A1 (no)
DE (1) DE602005003907D1 (no)
DK (1) DK1655030T3 (no)
EA (1) EA011212B1 (no)
ES (1) ES2298970T3 (no)
FR (1) FR2877338B1 (no)
GE (1) GEP20074256B (no)
HR (1) HRP20080119T5 (no)
MA (1) MA27917A1 (no)
MX (1) MXPA05011820A (no)
NO (1) NO20055167L (no)
NZ (1) NZ543358A (no)
PL (1) PL1655030T3 (no)
PT (1) PT1655030E (no)
SG (1) SG121999A1 (no)
SI (1) SI1655030T1 (no)
ZA (1) ZA200508911B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1781265B1 (en) * 2004-08-25 2010-04-07 Essentialis, Inc. Pharmaceutical formulations of potassium atp channel openers and uses thereof
WO2007081521A2 (en) 2006-01-05 2007-07-19 Essentialis, Inc. Salts of potassium atp channel openers and uses thereof
CN101795691A (zh) * 2007-07-02 2010-08-04 伊森舍丽斯有限公司 钾atp通道开放剂的盐及其用途
US8124793B2 (en) * 2007-11-27 2012-02-28 Gail Marie Cronyn, legal representative Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents
FR2943342B1 (fr) * 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US20120100229A1 (en) * 2009-03-27 2012-04-26 Yale University Treatment and Prevention of White Matter Injury with KATP Channel Activators
FR2955106B1 (fr) * 2010-01-08 2011-12-23 Servier Lab Nouveaux derives de benzothiadiazines cyclopropylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101633632B1 (ko) 2015-09-30 2016-06-27 김동용 방사능 차폐재

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
AU4345297A (en) * 1996-09-17 1998-04-14 Regents Of The University Of California, The Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
WO1999042456A2 (en) 1998-02-18 1999-08-26 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
FR2801587B1 (fr) * 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833956B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2833950B1 (fr) * 2001-12-21 2005-12-16 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PT1655030E (pt) 2008-02-08
ATE381338T1 (de) 2008-01-15
FR2877338B1 (fr) 2007-01-26
BRPI0504780A (pt) 2006-06-27
PL1655030T3 (pl) 2008-03-31
DK1655030T3 (da) 2008-04-28
US20060094712A1 (en) 2006-05-04
CA2524859A1 (fr) 2006-05-03
SI1655030T1 (sl) 2008-04-30
HRP20080119T5 (en) 2008-10-31
GEP20074256B (en) 2007-12-10
ZA200508911B (en) 2006-07-26
AU2005229698A1 (en) 2006-05-18
NZ543358A (en) 2007-04-27
HRP20080119T3 (en) 2008-04-30
AR051149A1 (es) 2006-12-20
SG121999A1 (en) 2006-05-26
US20070270415A1 (en) 2007-11-22
US7268130B2 (en) 2007-09-11
MXPA05011820A (es) 2006-05-08
EA200501530A1 (ru) 2006-06-30
EP1655030B1 (fr) 2007-12-19
CN1775767A (zh) 2006-05-24
EA011212B1 (ru) 2009-02-27
DE602005003907D1 (de) 2008-01-31
ES2298970T3 (es) 2008-05-16
FR2877338A1 (fr) 2006-05-05
JP2006151972A (ja) 2006-06-15
KR100818431B1 (ko) 2008-04-01
CN100396673C (zh) 2008-06-25
NO20055167D0 (no) 2005-11-03
MA27917A1 (fr) 2006-06-01
EP1655030A1 (fr) 2006-05-10
KR20060052410A (ko) 2006-05-19

Similar Documents

Publication Publication Date Title
NO20055167L (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20076006L (no) Acetylenderivater
NO20073325L (no) Nye naftalenforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
EA201101089A1 (ru) Производные оксадиазола в качестве агонистов рецептора s1p1
NO20083542L (no) Nye kumarinderivater med antitumoraktivitet
NO20091889L (no) Inhibitorer av spiroketon acetyl-CoA karboksylase
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
BRPI0718966B8 (pt) composto, composição farmacêutica, inibidor plk1 e agente antitumoral
TW200612920A (en) Novel imidazolidine derivatives
CO6300861A2 (es) Compuestos inhibidores de dipeptidil peptidasa iv metodos de preparacion de los mismos y composiciones farmaceuticas que los contienen como agentes activos
NO20075409L (no) Substituerte aminoalkyl- og amidoalkyl-benzopyranderivater
TW200800962A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
NO20076680L (no) Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20061045L (no) Imidazolderivater
NO20062083L (no) Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AR046753A1 (es) Derivados de benzoxazina y usos de los mismos
NO20091779L (no) Nye indolforbindelser en prosess for deres fremstilling og farmasoytiske sammensetninger som inneholder dem
NO20062100L (no) Nye fenylpyridylpiperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20050391L (no) Nye fluorinerte benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20041761L (no) Nye hydroksyalkylindolokarbazolforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20055124L (no) Nye benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
NO20045540L (no) Nye 3-(4-okso-4H-kromen-2-yl)-(1H)-kinolin-4-on-forbindelser, en fremgangsmate for deres fremstilling og farmasoytisk sammensetninger inneholdende dem

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application